Vaxxas holds an exclusive license from The University of Texas at Austin (UTA) to the SARS-CoV-2 spike subunit vaccine (HexaPro) for vaccination using a patch. HexaPro, a second-generation SARS-CoV-2 ...

The potential clinical utility of microarray-based diagnostics was then validated in stage II including another 1,152 patients, a cohort that represented an independent and blinded validation set for ...

Since their inception in 1995, DNA microarrays have become the icon of the genomics revolution. Everyone with any interest has become familiar with the images of precise rows and columns of colored ...

Multi-center Phase I clinical study will evaluate the safety and tolerability of a monovalent strain of avian influenza A (H7N9) vaccine delivered intradermally by Vaxxas’ high-density microarray ...

Planar waveguide (PWG) technology (right) has the advantage over conventional epifluorescence excitation (left) for surface-confined assays in that only surface-bound fluorphores respond to the ...

Multiplexing Breakthroughs, Automation, and Bioinformatics Convergence Position Protein Microarrays as a Strategic Imperative for Precision Medicine LeadersDelray Beach, FL, Feb. 24, 2026 (GLOBE ...

Atlanta (June 16 2025)-- Emory University and Micron Biomedical today announced the first clinical trial of a novel rotavirus vaccine, CC24, delivered via dissolvable microarray technology, is now ...

Processes Involved in Using DNA Microarray Instrumentation in Protein Microarray Workflow Protein microarrays offer the ability to measure protein expression and antibody binding in a high-throughput ...

Trial represents first-ever CDC-sponsored clinical trial of vaccine delivered via "patch” technology and utilizes Micron's first-in-class dissolvable microarray technology Research builds on Emory's ...